trial · primary record
Guselkumab
Crohn Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 530 |
| Primary completion | 2030-12-11 |
| Primary endpoint | Number of Participants with Deep Remission at Week 52 |
| Registry ID | NCT07499232 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:16.103Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07499232
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Guselkumab · approval
- Guselkumab · compound